SARS-CoV-2 infects coronary vessels, inducing plaque inflammation

SARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health.

AstraZeneca’s Truqap and Faslodex combo receives EU approval

The double-blinded and randomised trial enrolled 708 patients. Credit: National Cancer Institute on Unsplash. AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex

June 21, 2024

Weight-loss surgery may reduce pancreatic cancer risk in people with obesity

Obesity and type 2 diabetes are risk factors for various malignancies, including pancreatic cancer, which has a high death rate.

October 9, 2024

Abbott, Tandem launch new hybrid closed-loop insulin delivery system

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Tandem Diabetes Care integrated its

January 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.